Get the Stockscreener App
1.95
1.56%
0.03
After Hours:
1.95
Alector Inc stock is traded at $1.95, with a volume of 1.02M.
It is up +1.56% in the last 24 hours and down -17.37% over the past month.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
See More
Previous Close:
$1.92
Open:
$1.92
24h Volume:
1.02M
Relative Volume:
0.86
Market Cap:
$217.73M
Revenue:
$21.05M
Net Income/Loss:
$-142.93M
P/E Ratio:
-1.4034
EPS:
-1.3895
Net Cash Flow:
$-184.07M
1W Performance:
+2.09%
1M Performance:
-17.37%
6M Performance:
-10.14%
1Y Performance:
-33.45%
1-Day Range:
$1.90
$2.05
1-Week Range:
$1.85
$2.05
52-Week Range:
$1.09
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.95 | 217.73M | 21.05M | -142.93M | -184.07M | -1.3895 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-10-26 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alector Stock Price Forecast. Should You Buy ALEC? - StockInvest.us
Biotechnology Value Fund group discloses 8.4% stake in Alector (ALEC) - Stock Titan
ALEC Q2 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift Shares, Which Slip 5.41%Energy Earnings Report - careplusvn.com
Alector at Morgan Stanley conference: reset centers on brain delivery - Investing.com
Alector at Morgan Stanley conference: reset centers on brain delivery By Investing.com - Investing.com UK
Alector Inc. (ALEC) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Alector at Cantor healthcare conference: brain-shuttle pipeline in focus By Investing.com - Investing.com Canada
Alector at Cantor healthcare conference: brain-shuttle pipeline in focus - investing.com
ALEC: Alector Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Alector CFO Berkley Neil Lindsay Sells 29,251 Shares at $2.66 Each (NASDAQ: ALEC) - Kalkine Media
Alector (ALEC) Holds Steady at $2.47 as Support Level Comes into FocusBreakout Confirmation - dars.gov.et
Don't Ignore The Insider Selling In Alector - simplywall.st
Alector CEO Arnon Rosenthal sells $193,473 in stock By Investing.com - Investing.com South Africa
Alector CFO Neil Berkley sells $77,948 of ALEC shares By Investing.com - Investing.com Australia
Alector | 4: Statement of changes in beneficial ownership of securities - Moomoo
Alector’s Grace Wong-Sarad sells $24,665 in shares By Investing.com - Investing.com India
Alector | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Alector’s Grace Wong-Sarad sells $24,665 in shares - investing.com
Alector CEO Arnon Rosenthal sells $193,473 in stock - Investing.com
Preset trades at Alector (NASDAQ: ALEC) move 9,446 insider shares - Stock Titan
Alector (ALEC) CFO sells stock to cover RSU tax bill - Stock Titan
Alector (NASDAQ: ALEC) officer lines up another stock sale - Stock Titan
Alector Inc. (ALEC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Alector to Participate in Upcoming Healthcare Conferences - Yahoo Finance
Officer at Alector (NASDAQ: ALEC) lines up new stock sale after 3,475-share trade - Stock Titan
Tax-driven sale of 79K Alector (NASDAQ: ALEC) shares planned - Stock Titan
RSU taxes drive Alector (NASDAQ: ALEC) insider's 11K-share sale plan - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market SessionAlector (NASDAQ:ALEC), NeuroSense Therap - benzinga.com
Alector (ALEC) Update: Finishes 2.54% Down at $2.30 on the Day; Chart View: the Supplied Trading Band Runs From $2.18 to $2.42 in the Latest SessionSafe Entry Stocks - vinanet.vn
Alector (ALEC) CEO shifts 2.1M shares into family trusts - Stock Titan
Alector (ALEC) Results at a Glance: EPS Lands Above Forecast in Latest Trading; Latest Reaction: Shares Finish 9.95% Higher on the DayFree Cash Flow Trends - vinanet.vn
Merck & Co. Inc. Makes New $7.13 Billion Investment in Alector, Inc. $ALEC - MarketBeat
Alector, Inc. (NASDAQ:ALEC) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
ALEC Q2 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ResponseHigh Estimate Range - vinanet.vn
Industry Analysts Just Upgraded Their Alector, Inc. (NASDAQ:ALEC) Revenue Forecasts By 60% - simplywall.st
HC Wainwright Issues Negative Outlook for Alector Earnings - MarketBeat
BofA Securities Maintains Alector(ALEC.US) With Sell Rating, Announces Target Price $1 - Moomoo
Bank of America Securities Sticks to Its Sell Rating for Alector (ALEC) - The Globe and Mail
H.C. Wainwright Maintains Alector(ALEC.US) With Buy Rating, Maintains Target Price $5 - moomoo.com
Analysts Offer Insights on Healthcare Companies: Alector (ALEC), Genmab (GMAB) and Xenon (XENE) - The Globe and Mail
TD Cowen Maintains Alector(ALEC.US) With Hold Rating - Moomoo
Alector Inc (ALEC) Stock News Today - TradingKey
Alector Inc (ALEC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alector (ALEC) Declines 2.73% to $1.78 as Key Support at $1.69 Comes into FocusMFI Overbought - vinanet.vn
Alector earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Alector (NASDAQ:ALEC) Releases Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Alector, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Alector: Q2 Earnings Snapshot - Barchart.com
Alector, Inc. 2Q 2026: Revenue $3.32M, EPS $(0.21) — 10-Q Summary - TradingView
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):